April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Arndt Vogel Highlights Advances and Challenges in HER2-Targeted Therapies for Colorectal Cancer
Apr 28, 2025, 08:02

Arndt Vogel Highlights Advances and Challenges in HER2-Targeted Therapies for Colorectal Cancer

Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology at Hannover Medical School, shared on X:

“Advances and challenges in targeted therapies for HER2-amplified CRC, European J Cancer.

  • Excellent review HER2
  • overexpressed in ~6% of RAS WT
  • Trastuzumab/Tucatinib and T-Deruxtecan FDA approved , but still many open questions.”

Arndt Vogel Highlights Advances and Challenges in HER2-Targeted Therapies for Colorectal Cancer

Advances and challenges in targeted therapies for HER2-amplified colorectal cancer

Authors: Margot Pizzamiglio et al.

Arndt Vogel Highlights Advances and Challenges in HER2-Targeted Therapies for Colorectal Cancer

More posts featuring Arndt Vogel on OncoDaily.